CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Clinical Trials
Original article

Signant Health Unveils Patient-Centered Redesign of TrialMax® eCOA

Positive
AI Analysis

Summary

Signant Health announced a patient-centered redesign of its TrialMax® eCOA platform, available immediately for new clinical studies. The update modernizes the patient interface for electronic clinical outcome assessment.

Importance:2/10
Sentiment:
0.30
product_updateclinical_technologypatient_experienceeCOA
Related Companies

Read the original article

Published by PR Newswire Clinical Trials on September 1, 2026 1:00 PM

Read Original